Xcout Intel
GenrAb, Inc. competitors & alternatives
The 12 closest competitors and alternatives to GenrAb, Inc. among biotechnology companies — ranked by similarity to what GenrAb, Inc. actually does, not by market-cap band.
Subscribe to see GenrAb, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About GenrAb, Inc.
GenrAb, Inc. is a Dallas, Texas-based developer focused on creating first-in-class neuroprotective therapies. The company recently completed significant private financing to accelerate the development of its therapeutic pipeline.
GenrAb, Inc. at a glance
GenrAb, Inc. is a biotechnology company headquartered in United States. It has raised at least $10.2M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $5.6M in April 2025. Xcout tracks 7 named people at GenrAb, Inc., including Dr. Benjamin Greenberg (CEO/CMO).
GenrAb, Inc. leadership
- Dr. Benjamin GreenbergCEO/CMO
- Larry TiffanyChief Executive Officer
- Rich VincentCFO
- Richard VincentCFO and Secretary
- Dr. Nancy MonsonCSO
- Mr. Neil WarmaGenrAb Board Director
1 more named person on record for GenrAb, Inc., with roles, board committees and tenure — see the full roster →
GenrAb, Inc. funding rounds
At least $10.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5.6M | 5 named | |
| SEC Form D filing | $4.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 GenrAb, Inc. competitors
Ranked by semantic similarity — how close each company is to GenrAb, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Neurona Therapeutics Inc. is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.
Similar biotechnology company
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.
Biotech
NervGen Pharma Corp. is a biotechnology enterprise currently in its clinical development phase, focused on devising therapeutic solutions for nerve injuries and progressive neurodegenerative diseases. Their innovative approach centers on deactivating the natural biological mechanisms that typically impede the nervous system's ability to repair itself.
Similar biotechnology company
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Similar biotechnology company
Memgen, Inc. is a biotechnology research company focused on drug pipelines and science development programs, headquartered in Houston, Texas.
Similar biotechnology company
ProteKt Therapeutics is a biotechnology company founded in 2014 and headquartered in Beni-Brak, Israel, that develops novel therapeutics focusing on the nervous system and cellular protection.
Biotech
GeNeuro is a company headquartered in Geneva, Switzerland, with R&D facilities located in Lyon, France. The company has 19 employees and holds rights to 17 patent families protecting its technology.
Biotech
NeuroX1 Inc. is a for-profit biotechnology startup founded in 2021 with headquarters in Austin, Texas, operating a target identification and drug discovery platform that utilizes proprietary technology.
Similar biotechnology company
AriBio is a clinical-stage biopharmaceutical company founded in 2010 and headquartered in Seongnam, South Korea, with additional offices in the United States. The company focuses on developing novel therapeutics for neurodegenerative diseases.
Life Sciences
Cajal Neuroscience (Cajal Therapeutics Inc.) is a biotechnology company headquartered in Seattle, Washington. The company is dedicated to advancing therapeutic pipelines in neuroscience research.
Similar biotechnology company
Cyrano Therapeutics, Inc. is a regenerative medicine company headquartered in Delray Beach, Florida. The clinical-stage firm focuses on developing specialized pharmaceutical treatments and therapies for conditions related to smell loss.
Similar biotechnology company
Phoenix Biotechnology, Inc. is a San Antonio, Texas-based biotechnology company incorporated in 2003 to develop promising therapeutic agents and proprietary platforms.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of GenrAb, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for GenrAb, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →